Position history for BlackRock, Inc.'s holdings in CORVUS PHARMACEUTICALS INC
BlackRock, Inc. holds 6.2M shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $90.1M as of 2026-Q1. The position was increased (+21.8% shares). CRVS represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$90.1M
Current Shares
6.2M
Total Value Change
+$84.4M
Total Shares Change
+5.1M
Other major holders of CRVS: STATE STREET CORP, Point72 Asset Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP
Increased |
| 6.2M |
+21.8% |
| $90.1M |
| 0.0% |
| $17.53 |
36 |
| 2025-Q4 | Increased | 5.1M | +7.3% | $38.9M | 0.0% | $7.49 | 31 |
| 2025-Q3 | Increased | 4.7M | +11.1% | $34.7M | 0.0% | $7.28 | 32 |
| 2025-Q2 | Increased | 4.2M | +301.0% | $17M | 0.0% | $3.89 | 46 |
| 2025-Q1 | Decreased | 1.1M | -1.5% | $3.4M | 0.0% | $3.38 | 0 |
| 2024-Q4 | New | 1.1M | - | $5.7M | 0.0% | $5.25 | 37 |